Abstract
Thymic carcinoma is an uncommon neoplasm. The efficacy of second-line treatment with docetaxel in advanced thymic carcinoma has not been well studied. Therefore, we conducted a review of the efficacy of docetaxel-based chemotherapy as a second-line regimen for advanced thymic carcinoma. Fifteen patients with advanced thymic carcinoma who received second-line chemotherapy with docetaxel singlet or docetaxel/platinum combination chemotherapy regimens were retrospectively reviewed. There were 11 males and four females, with a median age of 53 years. Squamous cell carcinoma was most common (n = 10), followed by undifferentiated carcinoma (n = 4), and small cell carcinoma (n = 1). Eight patients received docetaxel/platinum combination chemotherapy and seven docetaxel mono-therapy. Four patients showed partial responses, representing a response rate of 26.7%. The median progression-free survival and overall survival in the 15 patients were 4.0 (2.8-5.2) and 22.0 (14.6-29.4) months, respectively. There was no difference in progression-free survival between the docetaxel singlet or docetaxel/platinum combination chemotherapy (3.5 months vs. 4.0 months, P = 0.889). A docetaxel-based regimen could be a potential therapeutic option as a s...Continue Reading
References
Jul 1, 1991·Cancer·A FornasieroM V Fiorentino
Jun 8, 2001·Cancer·P J LoehrerD H Johnson
Jun 1, 2002·American Journal of Clinical Oncology·Thomonobu KoizumiHisanori Saegusa
Apr 25, 2003·International Journal of Cancer. Journal International Du Cancer·Eric A Engels, Ruth M Pfeiffer
Jul 3, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frank FossellaChandra P Belani
Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick J LoehrerUNKNOWN Eastern Cooperative Oncology Group Phase II Trial
Dec 21, 2004·Chemotherapy·Tetsuya OguriRyuzo Ueda
Oct 11, 2008·Medical Oncology·Xiao-Feng LiYun-Bin Ye
May 5, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Satoshi IgawaNobuyuki Yamamoto
May 26, 2009·The Annals of Thoracic Surgery·Sandra TomaszekStefan Fischer
Nov 3, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G PalmieriG Di Lorenzo
Jun 24, 2010·British Journal of Cancer·P StröbelA Marx
Oct 19, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yusuke OkumaMasahiko Shibuya
Jun 15, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yusuke OkumaMasahiko Shibuya
Sep 11, 2012·Current Treatment Options in Oncology·Matthew A Gubens
Nov 28, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Y SunX-Q Zhang
Jan 15, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yusuke OkumaTatsuru Okamura